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OBJECTIVES The purpose of this study was to determine the potential value of magnetic resonance
myocardial perfusion in the follow-up of patients after coronary intervention.
BACKGROUND In some patients a residual impairment of myocardial perfusion reserve (MPR) early after
successful coronary intervention has been observed. In this study we evaluated an MPR index
before and after intervention with magnetic resonance.
METHODS Thirty-five patients with single- and multivessel coronary artery disease were studied before
and 24 h after intervention. The signal intensity time curves of the first pass of a
gadolinium-diethylene triamine pentacetic acid bolus injected via a central vein catheter were
evaluated before and after dipyridamole infusion. The upslope was determined using a linear
fit. Myocardial perfusion reserve index was estimated from the alterations of the upslope.
RESULTS The MPR index in segments perfused by the stenotic artery was significantly lower than in
the control segments (1.07 6 0.24 vs. 2.18 6 0.35, p , 0.001) and improved significantly
after intervention (1.89 6 0.39, p , 0.001) but did not normalize completely (p , 0.01).
After intervention the MPR index remained significantly lower in the balloon percutaneous
transluminal coronary angioplasty group (1.72 6 0.38; n 5 13) in comparison with the stent
group (1.99 6 0.36, n 5 18, p , 0.05). In the stent group a complete normalization of the
MPR index was found 24 h after stenting.
CONCLUSIONS Magnetic resonance perfusion measurements allow a reliable assessment of MPR index. An
improvement of MPR index can be observed after coronary intervention, which is more
pronounced after stenting. Magnetic resonance perfusion measurements allow the assessment
and may be useful for the follow-up of patients with coronary artery disease after coronary
intervention. (J Am Coll Cardiol 2000;36:1557–64) © 2000 by the American College of
Cardiology
Periprocedural Doppler flow and intravascular ultrasonic
examinations have shown that the initial morphological or
functional degree of the success of a percutaneous translu-
minal angioplasty (PTCA) is not always optimal (1–9) but
can be improved by the use of intravascular stents (10–13).
Several studies focused on the evaluation of myocardial
perfusion early after PTCA (8,14–19) and showed a resid-
ual early impairment in about 50% of the patients (4,9,20–
22). This impairment of myocardial perfusion after PTCA
has been attributed to incomplete and inadequate dilatation
of the stenotic coronary artery and, to a lesser extent, to
alterations of vascular resistance and response (10,11,19). A
frequent noninvasive follow-up of patients, with and with-
out stents, may help to decide whether a control angiogra-
phy is required or not since a reduction of blood flow and
incomplete luminal expansion after coronary intervention
can be responsible for the development of restenosis (23,24).
As chest pain has a low negative predictive value as a
clinical marker for the detection of restenosis in these
patients (25,26), an objective, noninvasive follow-up is
required. Currently, single photon emission tomography or
positron emission tomography (PET) are available for the
evaluation of myocardial perfusion (11,14,19,26–28); how-
ever, these techniques are limited by their dependency on
radioactive tracers, the long washout time for some tracers
making repeated measurements impractical, attenuation
artifacts in single photon emission computed tomography
and the dependency on an on site cyclotron for PET.
Cardiac magnetic resonance imaging (MR) is a promising
noninvasive technique that has recently been shown to be
more accurate for the detection of dobutamine-induced wall
motion abnormalities than echocardiography (29). In gen-
eral, evaluation of myocardial perfusion is even more prom-
ising since wall motion abnormalities occur later than the
reduction of myocardial perfusion in the ischemic cascade.
Cardiac MR allows the assessment of myocardial perfusion
by an analysis of the first pass kinetics of a contrast agent
bolus (3,30–33). We have shown in a previous study that
myocardial perfusion reserve (MPR) can be reproducibly
determined from the alterations of the upslope of a first pass
gadolinium-DTPA bolus after dipyridamole vasodilation
using a linear fit. In this prospective study of 40 patients we
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have shown a sensitivity of 92% and a specificity of 86% for
the detection of significant coronary artery stenosis by the
use of a previously defined ischemic threshold for MPR (3).
In reports of cardiac MR perfusion studies, Manning et
al. (30) found an increase of maximal signal intensity after
surgical revascularization, and Lauerma et al. (31) reported
an increase of the upslope in a group of 11 patients with
proximal single-vessel stenosis of the left anterior descend-
ing coronary artery (LAD) 3 months after PTCA or surgical
revascularization. In principle, these studies have demon-
strated that alterations of myocardial perfusion can be
assessed noninvasively with MR.
The aim of this study was to evaluate the changes of
MPR within 24 h of a successful coronary intervention in a
patient population with coronary artery disease (CAD).
Another purpose of this study was to determine the possible
diagnostic impact of this technique in the diagnosis and
follow-up of patients with CAD who have undergone
balloon PTCA or stenting.
METHODS
Patients. Thirty-eight patients (29 men, 9 women, age
59 6 10 years) with previously angiographically proven
significant single- or double-vessel CAD ($75% area ste-
nosis) referred for elective coronary intervention were pro-
spectively included in the study after written informed
consent. All patients had a stenosis of a major coronary
artery.
Patients were excluded if they had a history of prior
myocardial infarction, unstable angina, hemodynamic rele-
vant valvular disease, ventricular extrasystole $Lown III,
atrial fibrillation, ejection fraction ,30%, blood pressure
.160/95 mm Hg or ,100/70 mm Hg, obstructive pulmo-
nary disease, known claustrophobia or a contraindication for
an MR examination such as incompatible metallic implants.
Antianginal medication was stopped, and patients refrained
from drinks containing caffeine or theine for at least 12 h
before the examination.
Coronary angiography. After the MR examination, all
patients underwent left-sided cardiac catheterization and
biplane selective coronary angiography by the Judkins’
technique. Coronary stenoses were filmed in the center of
the field from multiple projections, and, as much as possible,
overlap of side branches and foreshortening of relevant
coronary stenoses was avoided. Coronary angiograms were
quantitatively assessed with the QANSAD QCA system
(trademark of ARRI, Munich, Germany) for high-grade
stenosis ($75% area stenosis). The examiner was blinded to
the MR examination. Coronary intervention was performed
with or without stenting based on the decision of the
physician performing the procedure.
MR imaging. All patients had a central vein catheter
placed in the superior vena cava via the right cubital vein.
The position of the catheter was controlled with x-ray and
corrected if needed. Patients were then examined in the
supine position with a 1.5 Tesla whole body MR tomograph
(ACS NT, Philips, Best, the Netherlands), which used a
five-element phased array cardiac surface coil. After two
rapid surveys to determine the exact position and axis of the
left ventricle, a short axis slice at the height of the origin of
the papillary muscles was chosen for perfusion imaging
using an electrocardiogram (ECG) triggered Tl-weighted
inversion recovery single shot turbo-gradient echo sequence
(inversion pulse, prepulse delay 360 ms, acquisition duration
360 ms, flip angle 15°, echo time 1.7 ms, repetition time
9 ms). Slice thickness was 8 mm with a spatial resolution of
1.7 3 1.9 mm. During a short expiratory breath hold of 10
heartbeats, 10 dynamic images without contrast agent were
acquired. During a second expiratory breath hold, a bolus of
gadolinium-DTPA 0.025 mmol/kg body weight (Mag-
nevist, Schering AG, Berlin, Germany) was rapidly injected
manually and flushed through with 0.9% NaCl 10 ml. Sixty
dynamic images (one image per heart beat) were acquired
during the first and second pass of the contrast agent (Fig.
1). Care was taken to achieve breath holding during the first
passage of the contrast agent through the myocardium to
minimize breathing artifacts. During the acquisition of later
images, the patients were allowed to take single deep breaths
when needed. After 15 min to allow for the clearance of the
first contrast agent injection, dipyridamole 0.56 mg/kg body
weight was administered for 4 min. Image acquisition was
repeated 2 min after the end of dipyridamole infusion.
During dipyridamole infusion an ECG rhythm strip was
continuously acquired by the use of standard MR equip-
ment. Blood pressure was measured once a minute with
standard equipment outside the scanning room by the use of
a pneumatic extension with the patient remaining in the
scanner. The dipyridamole infusion was discontinued upon
patient request or when chest discomfort occurred that was
indicative of progressive or severe angina or dyspnea, when
there was a decrease in systolic pressure (.40 mm Hg),
when there was severe supraventricular or ventricular ar-
rhythmias or other adverse effects. Aminophylline was
administered as clinically required. The MR study was
repeated 24 h after coronary intervention using an identical
protocol to that used before intervention.
Image analysis. In all images the endo- and epicardial
contours were traced by an examiner who was blinded to the
angiographic results, by the use of a custom written program
Abbreviations and Acronyms
CAD 5 coronary artery disease
ECG 5 electrocardiogram
LAD 5 left anterior descending coronary artery
LCX 5 left circumflex coronary artery
MPR 5 myocardial perfusion reserve
MR 5 magnetic resonance
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PTCA 5 percutaneous transluminal coronary
angioplasty
RCA 5 right coronary artery
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on a Sun Sparc workstation and corrected manually for
changes of diaphragmatic position due to breathing or
diaphragmatic drift. Care was taken to place the contours on
the myocardium and to exclude the left ventricular cavity
and the pericardium. The myocardium was then divided
into six equiangular segments and numbered clockwise
beginning with the anterior septal insertion of the right
ventricle (Fig. 2). An additional region of interest was
Figure 1. A selection of magnetic resonance images of the transit of the gadolinium bolus through the right ventricle, the left ventricle and the left
ventricular myocardium. Arrows indicate the borders of the visual perfusion defect from a 95% stenosis of the left anterior descending coronary artery in
the corresponding territory.
Figure 2. The left ventricular myocardium was divided into six equiangular segments. The segments as shown were assigned to coronary arteries by the use
of invasive angiography. The resultant signal intensity versus time curves of the myocardial segments and of the left ventricular cavity was plotted. LAD 5
left anterior descending coronary artery; LCX 5 left circumflex coronary artery; LV 5 left ventricular cavity; RCA 5 right coronary artery; RV 5 right
ventricle; s 5 seconds; SI 5 signal intensity (arbitrary units).
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placed within the cavity of the left ventricle, which excluded
the myocardial segments and the papillary muscles. Images
acquired after premature ventricular beats or insufficient
cardiac triggering were excluded from the analysis to min-
imize artifacts. Signal intensity was determined for all
dynamics and segments (Fig. 2). The signal intensity before
contrast agent administration was subtracted, and the up-
slope of the resulting signal intensity time curve was
determined by the use of a linear fit. To enable the
comparison of different signal intensity curves, possible
differences of the input function needed to be considered.
The results of the myocardial segments were corrected for
the input function by dividing the upslope of each myocar-
dial segment by the upslope of the left ventricular signal
intensity time curve, which was regarded as a measure of the
input function. For the estimation of perfusion reserve (34),
an upslope index was calculated by dividing the results at
maximum vasodilatation by the results at rest. This upslope
index correlates with MPR and is referred to as the MPR
index. Two experienced observers decided which of the six
myocardial segments was supplied by which coronary artery.
Segments 1 and 6 were always assigned to the LAD,
segment 3 to the left circumflex coronary artery (LCX) and
segment 5 to the right coronary artery (RCA). Segment 2
was either assigned to the LAD or the LCX, dependent
upon the angiographic appearance, and segment 4 was
assigned in the same manner either to the LCX or to the
RCA (Fig. 2).
The MPR index was calculated for all segments. If the
MPR index was less than or equal to 1.5, the segment was
classified as pathological and defined as ischemic, indicating
hypoperfusion; if it was more than the ischemic threshold, it
was defined as nonischemic, indicating normal perfusion.
This threshold was determined previously (3). If at least one
segment within the territory of a coronary artery was found
to be ischemic, MR was regarded as positive for that region.
If more than one segment in the territory of a stenotic
coronary artery was ischemic, the MPR index was averaged
for these segments. For the comparison of the results before
and after intervention, the same segments were evaluated. In
the patients with single-vessel disease, the contralateral
segments opposite the ischemic segment in the territory of
the stenotic coronary artery were regarded as normally
perfused, that is, nonischemic, and were used as control
segments for the MPR index.
Statistical analysis. If not otherwise stated, continuous
data are presented as mean 61 standard deviations. An
unpaired or paired two-tailed Student t test was used for
differences between groups. A two-way repeated measure-
ment analysis of variance was used to test for group (control,
stent, balloon) and intervention (before/after) effect and
their interactions. In addition an univariate analysis of
variance was performed to compare the measures of the
stent after intervention and balloon PTCA group and the
control group. To adjust for multiple testing, Sidak’s test
was applied. A p value of ,0.05 was considered statistically
significant.
RESULTS
Dipyridamole stress MR perfusion imaging was successfully
performed in 35 out of 38 patients (92%). Cardiac MR
examination could not be performed in one patient due to
claustrophobia, in another due to insufficient ECG trigger-
ing and in one due to the occurrence of uncomplicated
ventricular arrhythmias after PTCA, which required con-
tinuous monitoring on a coronary care unit for the first 24 h
after PTCA.
The clinical data of the patient population are given in
Table 1. Fifty-two coronary artery stenoses were found by
angiography. Twenty-one patients had stenoses of the
LAD, 15 of the LCX and 16 of the RCA. Twenty patients
(57%) had single- and 12 had (34%) double-vessel disease.
In three patients (9%) triple-vessel disease was found despite
previously expected double-vessel disease, and two of them
were referred for surgical revascularization. In the remaining
patients coronary intervention was successfully performed
(residual area stenosis of ,75%) in all but two who had a
subtotal occlusion of the coronary artery. In 20 vessels of 15
patients with multivessel disease, no intervention was per-
formed; thus, 22 stenotic vessels remained during follow-up.
The characteristics of the coronary arteries before and after
intervention are given in Table 2. All patients had normal
wall motion on ventriculographic examination.
No serious adverse effects occurred during the angiogra-
phy, the coronary intervention or the cardiac MR examina-
tion. Other than the frequent minor side effects of dipyrid-
amole, one patient developed a mild uncomplicated
phlebitis of the cubital vein at the site of the central venous
catheter, which resolved quickly after removal of the cath-
eter without the need for antibiotic therapy.
In 793 of 840 segments (94%) evaluated before and after
dipyridamole, a linear fit was performed. Forty-seven seg-
ments could not be analyzed due to noise or artifacts.
Before intervention the MPR index was 1.13 6 0.25 in
segments supplied by a stenotic coronary artery and 2.18 6
0.35 in control segments (p , 0.001). Forty-seven of the 53
territories supplied by stenotic coronary arteries and 43 of
the 52 territories supplied by nonstenotic coronary arteries
were correctly diagnosed as ischemic and nonischemic,
respectively, by the use of the previously defined threshold
of 1.5. This resulted in a sensitivity of 89% and a specificity
of 83% with a diagnostic accuracy of 86%.
Table 1. Patient Population
Men/women 27/8
Age 59 6 10
BSA 1.98 6 0.22
CI (l/min per m2) 4.0 6 1.3
EF (%) 58 6 10
Continuous values are presented as mean 6 one standard deviation.
BSA 5 body surface area; CI 5 cardiac index; EF 5 ejection fraction determined
by planimetric evaluation of the ventriculographic examination.
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The group effect for the three groups—controls, stent
and balloon revascularization—was significant (p , 0.001).
The intervention effect of the balloon and stent groups
showed significant differences, comparing before and after
intervention (p , 0.0001). Between the three groups
(control, stent and balloon) there was a significant interac-
tion effect (p , 0.0001) showing the different effects of stent
and balloon treatment.
After intervention, the MPR index increased significantly
in segments supplied by successfully treated vessels (1.07 6
0.24 before and 1.89 6 0.39 after intervention, p , 0.001);
however, it remained below the levels of the control seg-
ments (p , 0.01) (Fig. 3). The subgroup of patients treated
with stents (n 5 18) showed no significant differences of the
MPR index (1.99 6 0.36 vs. 2.18 6 0.35, p 5 0.54),
whereas those treated with balloon PTCA (n 5 13) had
levels that remained below the control group (1.72 6 0.38,
p 5 0.003) and also below the patients treated with stents
(p 5 0.029). The increase in the MPR index was signifi-
cantly higher in patients treated with stents (206 6 67%)
when compared with those without stents (164 6 49%, p 5
0.02) (Fig. 4). In three patients (11%) who had undergone
a successful intervention and who were in the balloon
PTCA group, the MPR index increased after angioplasty
but remained below the ischemic threshold of 1.5. After
coronary intervention, sensitivity and specificity for the
detection of a stenotic coronary artery were 82% and 84%,
respectively, which resulted in a diagnostic accuracy of 84%.
DISCUSSION
With cardiac MR for the assessment of the outcome of
coronary intervention for patients, an MPR index can be
successfully determined. The MPR index in ischemic seg-
ments improved significantly after successful angioplasty but
did not normalize when compared with nonischemic con-
trol segments of patients with single-vessel disease. Im-
provement was significantly greater if the vessel was stented,
as opposed to balloon PTCA. The detection of significant
Figure 3. Myocardial perfusion reserve index in the control segments
(segments contralateral to ischemic segments in patients with single
coronary artery disease) when compared with MPRI in segments supplied
by stenotic coronary arteries before and after intervention. All values are
presented as single values and mean 6 one standard deviation. MPRI 5
myocardial perfusion reserve index; PTCA 5 percutaneous transluminal
coronary angioplasty.
Figure 4. Improvement of MPRI after intervention in patients treated with
stents compared with balloon PTCA. Values are presented as single values,
mean 6 one standard deviation and percentage increment of MPRI.
MPRI 5 myocardial perfusion reserve index.
Table 2. Characteristics of the Treated Coronary Arteries
Reference
Vessel
Diameter
(mm)
Area Stenosis
Before
Intervention
(%)
Minimal Lumen
Diameter Before
Intervention
(mm)
Minimal Lumen
Diameter After
Intervention
(mm)
All patients (n 5 31) 3.1 6 0.7 93 0.84 6 0.44 2.58 6 0.59
Stent group (n 5 18) 3.2 6 0.7 93 0.8 6 0.45 2.72 6 0.58
Balloon group (n 5 13) 2.9 6 0.5 87 0.88 6 0.44 2.4 6 0.54
Reference vessel diameter was determined as the mean diameter of the vessel proximal and distal to the stenosis determined by
quantitative coronary angiography presented as mean 6 one standard deviation. Stenosis before intervention is given as % area
reduction (median). Minimal lumen diameter is presented as mean 6 one standard deviation. Differences between the stent and
balloon groups were not significant.
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CAD with cardiac MR perfusion measurements yielded a
high diagnostic accuracy with a sensitivity and specificity of
89% and 83% before and 82% and 84% after coronary
intervention by the use of an ischemic threshold value
defined in a previous study that used an identical technique
(3).
Comparison of balloon PTCA and stenting. Although
the MPR index improved in all revascularized segments, it
remained impaired when compared with control segments
(1.89 6 0.44 vs. 2.18 6 0.35). A similar impairment of
myocardial or coronary flow reserve was reported in 20 to
45% of the patients after PTCA (4,15,19–22,35,36). This
fraction may reflect patients with suboptimal results of
PTCA (10,11,19) who are at higher risk of developing
restenosis on subsequent follow-up (13,27). An early im-
pairment of myocardial perfusion after PTCA has been
explained by several factors either directly related to the
barotrauma, such as perivascular edema, small intimal dis-
section, recoil, mural thrombus formation, microemboliza-
tion, or to alterations of vascular tonus and flow, reduced
vascular response to vasodilators, abnormal autoregulation
of the resistive vessels or the release of vasoconstrictors
(9,28,37–41). However, the amount of impairment of
coronary flow reserve after coronary intervention has been
found to be mainly related to the degree of residual stenosis
(10), which lead to the observation that better coronary
artery blood flow is achieved after stent implantation when
compared with balloon PTCA due to the larger and more
circular lumen, the inhibition of recoil and to overcoming
intimal dissection (42–44). This partially explains the lower
incidence of restenosis after stenting when compared with
balloon PTCA (45,46). In this study an impairment of
MPR index after balloon PTCA with complete normaliza-
tion after stenting was observed. This impairment reflects
suboptimal results after balloon PTCA, even though this
may not be visible during the procedure. In this analysis
three treated patients had an MPR below the threshold
value for significant coronary artery stenosis in the territory
of the revascularized coronary artery. One of these patients
had a residual stenosis of 58%, another one had a small
dissection that was not visualized initially during the pro-
cedure. Thus, these patients may indeed have myocardial
ischemia during dipyridamole infusion rather than false
positive cardiac MR results. No significant differences of
hemodynamic parameters were found that could explain the
remaining impairment of MPR index after intervention. An
influence of the delay of the measurements after interven-
tion can be excluded because all measurements were per-
formed 18 to 26 h after intervention.
MPR index after intervention. After intervention, four of
the 22 remaining stenotic coronary arteries were diagnosed
as nonstenotic by cardiac MR perfusion imaging. In two of
these patients the same segment had already been classified
as ischemic by the perfusion measurements before interven-
tion. In contrast, the other two segments were correctly
classified as ischemic before intervention but improved to
normal after intervention of a different vessel without
treatment of the vessel defined to supply this segment.
Thus, these two segments may indeed have developed
normal perfusion reserve index due to better collateraliza-
tion after intervention.
Study limitations. Several limitations apply to this study.
For technical reasons at the time of the study, only a single
slice technique was used; thus, small perfusion defects at
basal or apical segments may have been missed. However,
only patients with stenoses of major coronary arteries, who
were expected to have rather large perfusion defects, were
included. New techniques enable the acquisition of multiple
slices with good spatial resolution within one heartbeat,
which should further improve the diagnostic accuracy of
cardiac MR myocardial perfusion imaging (47).
No comparison of the cardiac MR perfusion measure-
ments with scintigraphy or PET was performed. However,
although cardiac MR shows a greater failure rate mainly due
to claustrophobia, scintigraphic methods are limited by
known problems, such as low spatial resolution and atten-
uation artifacts that lead to a decrease of diagnostic accu-
racy, especially of the posterior regions, with a low speci-
ficity. Despite the low spatial resolution, PET may currently
be the optimal reference standard. In clinical practice
angiography serves as the reference standard to decide
whether a significant coronary artery stenosis is present and
if an intervention is required. Thus, in this study cardiac
MR perfusion measurements were compared with invasive
angiography.
To optimize the kinetics of the contrast agent bolus, a
central venous catheter was placed in all patients, which
cannot be done if this technique is used routinely in larger
patient populations, due to the semi-invasiveness of this
procedure. However, the results of this study show that a
linear fit of the upslope can be reliably used to detect
significant coronary artery stenoses and to assess alterations
of MPR after angioplasty. In contrast with previously
suggested fitting procedures (33) that require a sufficient
number of data points in the downslope of the first pass
contrast agent curve (32), the analysis of the upslope can
also be performed with peripheral injection and will be used
in further studies in our institution.
Currently, analysis time is approximately 60 min per
patient. Further optimization and automatization of post-
processing analysis is required before this technique can be
introduced into clinical routine. However, prototype soft-
ware is available at several institutions, which reduces
evaluation time dramatically.
The long acquisition time results in a significant through
plane motion during acquisition and may result in discrep-
ancies in the assignment of the segments to the territories
and an error in comparing similar segments. However, large
segments were compared rather than a pixel to pixel
analysis, which will be more sensitive to through plane
motion. Improvements of the MR hard- and software allow
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much faster data acquisition, which will minimize this effect
(47).
Conclusions. Cardiac MR perfusion measurements allow
for accurate evaluation of MPR index. Significant coronary
artery stenoses can be detected with high diagnostic accu-
racy. After coronary intervention an improvement in MPR
index was found, which was more pronounced after stent-
ing. This technique may be useful for the follow-up and
control of patients with CAD after coronary intervention.
Reprint requests and correspondence: Dr. Eike Nagel, Internal
Medicine/Cardiology, German Heart Institute & Charite´ Campus
Virchow, Humboldt University, Augustenburger Platz 1, D-13353
Berlin/Germany. E-mail: eike.nagel@dhzb.de.
REFERENCES
1. Tobis JM, Mallery J, Mahon D, et al. Intravascular ultrasound imaging
of human coronary arteries in vivo: analysis of tissue characterizations
with comparison to in vitro histological specimens. Circulation 1991;
83:913–26.
2. Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan
HM. Intracoronary ultrasound imaging: correlation of plaque mor-
phology with angiography, clinical syndrome and procedural results in
patients undergoing coronary angioplasty. J Am Coll Cardiol 1993;
21:35–44.
3. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of
myocardial ischemia from perfusion reserve based on cardiovascular
magnetic resonance. Circulation 2000;101:1379–83.
4. Wilson RF, Johnson MR, Marcus ML, et al. The effect of coronary
angioplasty on coronary flow reserve. Circulation 1988;77:873–85.
5. Ofili EO, Kern MJ, Labovitz AJ, et al. Analysis of coronary blood flow
velocity dynamics in angiographically normal and stenosed arteries
before and after endolumen enlargement by angioplasty. J Am Coll
Cardiol 1993;21:308–16.
6. Nishioka T, Luo H, Eigler NL, et al. The evolving utility of
intracoronary ultrasound. Am J Cardiol 1995;75:539–41.
7. Pijls NH, Aengevaeren WR, Uijen GJ, et al. Concept of maximal flow
ratio for immediate evaluation of percutaneous transluminal coronary
angioplasty result by videodensitometry. Circulation 1991;83:854–65.
8. Segal J, Kern MJ, Scott NA, et al. Alterations of phasic coronary artery
flow velocity in humans during percutaneous coronary angioplasty.
J Am Coll Cardiol 1992;20:276–86.
9. van Liebergen RA, Piek JJ, Koch KT, de Winter RJ, Lie KI.
Immediate and long-term effect of balloon angioplasty or stent
implantation on the absolute and relative coronary blood flow velocity
reserve. Circulation 1998;98:2133–40.
10. Kern MJ, Dupouy P, Drury JH, et al. Role of coronary artery lumen
enlargement in improving coronary blood flow after balloon angio-
plasty and stenting: a combined intravascular ultrasound Doppler flow
and imaging study. J Am Coll Cardiol 1997;29:1520–7.
11. Versaci F, Tomai F, Nudi F, et al. Differences of regional coronary
flow reserve assessed by adenosine thallium-201 scintigraphy early and
6 months after successful percutaneous transluminal coronary angio-
plasty or stent implantation. Am J Cardiol 1996;78:1097–102.
12. Ge J, Erbel R, Zamorano J, et al. Improvement of coronary morphol-
ogy and blood flow after stenting: assessment by intravascular ultra-
sound and intracoronary Doppler. Int J Card Imaging 1995;11:81–7.
13. Serruys PW, di Mario C, Piek J, et al. Prognostic value of intracoro-
nary flow velocity and diameter stenosis in assessing the short- and
long-term outcomes of coronary balloon angioplasty: the DEBATE
study (Doppler End points Balloon Angioplasty Trial Europe). Cir-
culation 1997;96:3369–77.
14. Walsh MN, Geltman EM, Steele RL, et al. Augmented myocardial
perfusion reserve after coronary angioplasty quantified by positron
emission tomography with H2(15)O. J Am Coll Cardiol 1990;15:
119–27.
15. Kern MJ, Deligonul U, Vandormael M, et al. Impaired coronary
vasodilator reserve in the immediate postcoronary angioplasty period:
analysis of coronary artery flow velocity indexes and regional cardiac
venous efflux. J Am Coll Cardiol 1989;13:860–72.
16. Perchet H, Dupouy P, Duval Moulin AM, et al. Improvement of
subendocardial myocardial perfusion after percutaneous transluminal
coronary angioplasty: a myocardial contrast echocardiography study
with correlation between myocardial contrast reserve and Doppler
coronary reserve. Circulation 1995;91:1419–26.
17. Vassanelli C, Menegatti G, Molinari J, et al. Maximal myocardial
perfusion by videodensitometry in the assessment of the early and late
results of coronary angioplasty: relationship with coronary artery
measurements and left ventricular function at rest. Cathet Cardiovasc
Diagn 1995;34:301–12.
18. Miller DD, Verani MS. Current status of myocardial perfusion
imaging after percutaneous transluminal coronary angioplasty. J Am
Coll Cardiol 1994;24:260–6.
19. Iskandrian AS, Lemlek J, Ogilby JD, Untereker WJ, Cave V, Heo J.
Early thallium imaging after percutaneous transluminal coronary
angioplasty: tomographic evaluation during adenosine-induced coro-
nary hyperemia. J Nucl Med 1992;33:2086–9.
20. O’Neill WW, Walton JA, Bates ER, et al. Criteria for successful
coronary angioplasty as assessed by alterations in coronary vasodilatory
reserve. J Am Coll Cardiol 1984;3:1382–90.
21. Zijlstra F, Reiber JC, Juilliere Y, Serruys PW. Normalization of
coronary flow reserve by percutaneous transluminal coronary angio-
plasty. Am J Cardiol 1988;61:55–60.
22. Cloninger KG, DePuey EG, Garcia EV, et al. Incomplete redistribu-
tion in delayed thallium-201 single photon emission computed tomo-
graphic (SPECT) images: an overestimation of myocardial scarring.
J Am Coll Cardiol 1988;12:955–63.
23. Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. Shear stress
regulation of artery lumen diameter in experimental atherogenesis. J
Vasc Surg 1987;5:413–20.
24. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty.
Potential biologic determinants and role of intimal hyperplasia. Cir-
culation 1989;79:1374–87.
25. Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis
after elective percutaneous transluminal coronary angioplasty using the
exercise treadmill test. Am J Cardiol 1990;65:28–34.
26. Hecht HS, Shaw RE, Chin HL, Ryan C, Stertzer SH, Myler RK.
Silent ischemia after coronary angioplasty: evaluation of restenosis and
extent of ischemia in asymptomatic patients by tomographic thallium-
201 exercise imaging and comparison with symptomatic patients. J Am
Coll Cardiol 1991;17:670–7.
27. Hardoff R, Shefer A, Gips S, et al. Predicting late restenosis after
coronary angioplasty by very early (12 to 24 h) thallium-201 scintig-
raphy: implications with regard to mechanisms of late coronary
restenosis. J Am Coll Cardiol 1990;15:1486–92.
28. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A.
Delayed recovery of coronary resistive vessel function after coronary
angioplasty. J Am Coll Cardiol 1993;21:612–21.
29. Nagel E, Lehmkuhl H, Bocksch W, et al. Noninvasive diagnosis of
ischemia-induced wall motion abnormalities with the use of high-dose
dobutamine stress MRI. Circulation 1999;99:763–70.
30. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR.
First-pass nuclear magnetic resonance imaging studies using
gadolinium-DTPA in patients with coronary artery disease. J Am Coll
Cardiol 1991;18:959–65.
31. Lauerma K, Virtanen KS, Sipila LM, Hekali P, Aronen HJ. Multislice
MRI in assessment of myocardial perfusion in patients with single-
vessel proximal left anterior descending coronary artery disease before
and after revascularization. Circulation 1997;96:2859–67.
32. Keijer JT, van Rossum AC, van Eenige MJ, et al. Semiquantitation of
regional myocardial blood flow in normal human subjects by first-pass
magnetic resonance imaging. Am Heart J 1995;130:893–901.
33. Wilke N, Jerosch Herold M, Wang Y, et al. Myocardial perfusion
reserve: assessment with multisection, quantitative, first-pass MR
imaging. Radiology 1997;204:373–84.
34. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assess-
ing critical coronary stenosis. Instantaneous flow response and regional
distribution during coronary hyperemia as measures of coronary flow
reserve. Am J Cardiol 1974;33:87–94.
35. Lang RM, Feinstein SB, Feldman T, Neumann A, Chua KG,
1563JACC Vol. 36, No. 5, 2000 Al-Saadi et al.
November 1, 2000:1557–64 MR Myocardial Perfusion Reserve Index After Intervention
Borow KM. Contrast echocardiography for evaluation of myocardial
perfusion: effects of coronary angioplasty. J Am Coll Cardiol 1986;8:
232–5.
36. Reisner SA, Gottlieb S, Ernst A, et al. Myocardial contrast echocar-
diography: influence of ischemia and hyperemia in an animal model.
Eur Heart J 1992;13:383–8.
37. Waller BF. “Crackers, breakers, stretchers, drillers, scrapers, shavers,
burners, welders and melters”—the future treatment of atherosclerotic
coronary artery disease? A clinical-morphologic assessment. J Am Coll
Cardiol 1989;13:969–87.
38. Fischell TA, Bausback KN, McDonald TV. Evidence for altered
epicardial coronary artery autoregulation as a cause of distal coronary
vasoconstriction after successful percutaneous transluminal coronary
angioplasty. J Clin Invest 1990;86:575–84.
39. Nanto S, Kodama K, Hori M, et al. Temporal increase in resting
coronary blood flow causes an impairment of coronary flow reserve
after coronary angioplasty. Am Heart J 1992;123:28–36.
40. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri
A. Effect of intracoronary serotonin on coronary vessels in patients
with stable angina and patients with variant angina. N Engl J Med
1991;324:648–54.
41. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin
released during coronary angioplasty. N Engl J Med 1994;330:523–8.
42. Gorge G, Haude M, Ge J, et al. Intravascular ultrasound after low and
high inflation pressure coronary artery stent implantation. J Am Coll
Cardiol 1995;26:725–30.
43. Painter JA, Mintz GS, Wong SC, et al. Serial intravascular ultrasound
studies fail to show evidence of chronic Palmaz-Schatz stent recoil.
Am J Cardiol 1995;75:398–400.
44. Haude M, Erbel R, Straub U, Dietz U, Schatz R, Meyer J. Results of
intracoronary stents for management of coronary dissection after
balloon angioplasty. Am J Cardiol 1991;67:691–6.
45. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison
of coronary-stent placement and balloon angioplasty in the treatment
of coronary artery disease. Stent Restenosis Study Investigators.
N Engl J Med 1994;331:496–501.
46. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of
balloon-expandable stent implantation with balloon angioplasty in
patients with coronary artery disease. Benestent Study Group. N Engl
J Med 1994;331:489–95.
47. Schwitter J, Debatin JF, von Schulthess GK, McKinnon GC. Normal
myocardial perfusion assessed with multishot echo-planar imaging.
Magn Reson Med 1997;37:140–7.
1564 Al-Saadi et al. JACC Vol. 36, No. 5, 2000
MR Myocardial Perfusion Reserve Index After Intervention November 1, 2000:1557–64
